FDA Investigator Laishan L Lam

Laishan L Lam has inspections in 1 countries as of 27 Jul 2023. Laishan L Lam has collaborated with a combinined 2325 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
190
Last Inspection Date:
27 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Albert M Brindle, Alberto A Viciedo, Allen Lou, Amy L Singer, Amy M Codella, Amy M Cramer, Anastasia I Offordile, Andrew J Molesky, Anita R Michael, Annemarie Bodnar, Anthony M Criscuolo, Jr, Antoinette L Ravelli, Atul J Agrawal, Ayorinde O Babalola, Barbara J Maulfair, Benjamin Bustamante, Cara M Minelli, Cary Greene, Cassandra Gasby, Celia L Hutchinstein, Charles I Ann, Charles J Chacko, Christian Parra, Christina N Maurino, Craig W Swanson, Daniel W Johnson, David H Smith, Dawn L Wydner, Devon Jenkins, Dhaval H Patel, Diane B Radice, Douglas C Kovacs, Dung N Tran, Edward Oshaughnessy, Emest F Bizjak, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Erin Rothschild, Frank A Boardwick, Frank J Marciniak, Gianine E Delade, Gianine E Tompkins, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, Herrmann, Hitesh R Patel, Jananiga Vanniyasingam, Janet A Rajan, Jason Kwong, Jason M Sluzynski, Jeffrey J Ebersole, Jerri E Lothrop, Jessica M Monteiro, Jill M Sooter, Jogy George, John P Sakowski, Jonah S Ufferfilge, Jose M Cayuela, Joseph Duca, Joseph S Fanelli, Joy F Canlas, Joy Rkozlowski Klena, Karen E D'orazio, Karen F Tomaziefski, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kelly I Anderson, Kendra L Brooks, Kerry A Donovan, Kerry A Kurdilla, Kimberly A Coward, King, Kinh Q Mac, Kris K Moore, Kristy A Zielny, Krystal O Ogunremi, L Izaam Lam, L Zam Lam, Larry Johnson, Lawrence R Johnson, Leticia S Jones, Li Li, Liatte Kreuger, PharmD, Lisa B Hall, Lisa Harlan, Loretta Nemchik, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marie T Falcone, Marjorie D Schultz, Melissa B Libby, Melissa T Roy, Mercedes Mota, Meredith L Sheridan, Merril E Racke, Michael Serrano, Miguel G Manzano, Nancy F Scheraga, Nicholas E Squillante, Niketa Patel, Nina Yang, Paul L Bellamy, Peter R Lenahan, Raymond L Cheung, Raymond Liu, Regina T Brown, Remache, Richard D Manney, Rita F Monfort, Robert Sharpnack, Rodrigo Vilchez, Saleem A Akhtar, Sandra Kershaw, Sands, Sarah Forney, Schultz, Sherri J Liu, Shirley S Wen, Sinai Davis, State Agency, Stephanie T Durso, Stephen J Mottola, Susan M Halsted, Tania E Vizcaino, Tara G Bizjak, Tara K Carmody, Teigan M Mule, Tonia F Bernard, Tressa T Lewis, Vaishali J Patel, Valerie C Reed, Wayne J Meyer, Whitney S Reynolds, Willy A Orantes, Zakaria I Ganiyu

Laishan L Lam's Documents

Publish Date Document Type Title
June, 2010 EIR Triarco Industries, Inc. - EIR, 2010-06-02
June, 2009 FDA 483 Citrus Products Inc. - Form 483, 2009-06-01
November, 2001 EIR Colorcon, Inc - EIR, 2001-11-02
February, 2002 EIR Suprema Specialties Inc - EIR, 2002-02-28
August, 2000 EIR Suprema Specialties Inc - EIR, 2000-08-24

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more